Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

NCT05994365 · clinicaltrials.gov ↗

RECRUITING

Status

380

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Neoplasms

Interventions

DRUG: Anlotinib Hydrochloride Capsule

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.